Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition
Zevra Therapeutics announced that Chief Medical Officer Adrian Quartel will step down effective July 3, 2026, citing personal reasons. Dr. Quartel will remain in a consulting capacity through December 31, 2026, to ensure a seamless transition while the company searches for a successor.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.